Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

SkinViva Doctor Introduces ‘Tear Trough’ Anti-Ageing Treatment for Eye Area
  • USA - English


News provided by

SkinViva

Mar 28, 2014, 11:15 ET

Share this article

Share toX

Share this article

Share toX

Dr Tim Pearce MB ChB BSc (Hons) MRCGP
Dr Tim Pearce MB ChB BSc (Hons) MRCGP

Manchester (PRWEB UK) 28 March 2014 -- The eyes are said to be the most expressive and attractive part of the face, but the delicate skin in the area is often the first to show signs of ageing.

While many non-surgical treatment practitioners shy away from this area, Dr Tim Pearce, founder and Clinical Director of SkinViva has developed his own unique method of rejuvenating the eye area by tackling the signs of tiredness such as under eye shadows or hollows, tired eyes, dark circles and tear troughs.

The treatment of the shadow that develops under the eyes has become one of my favourite areas to treat. Many of my clients do not realise it is even possible until they have had a detailed consultation.

Post this

The under eye line develops as volume loss occurs in the face, often along with smile lines or the nose to mouth lines. The skin is delicate and thin and the fine dynamic facial muscles are in constant use as the eyes focus; with continuous movement as a range of emotions are communicated.

SkinViva’s Tear Trough Anti-Ageing Treatment involves careful and highly precise use of the very latest injectable facial filler products to sculpt and smooth the hollows and dark circles that can appear around the eye. The process demands exacting skill and a particularly delicate touch, but results are instantaneous and highly effective.

Dr Tim Pearce MB ChB BSc (Hons) MRCGP explains more:

“One of the best things about this treatment is the natural looking results it delivers and how it instantly makes patients look less tired and generally fresher.”

“The treatment of the shadow that develops under the eyes has become one of my favourite areas to treat. Many of my clients do not realise it is even possible until they have had a detailed consultation.”

SkinViva’s doctors use the very latest Juvéderm® fillers. Based on a formula of hyaluronic acid, which occurs naturally in the skin but depletes over time, these fillers retain water to add volume back into ageing skin. Dr Tim Pearce favours Juvéderm® VOLBELLA®, which has a ground-breaking formulation which means a lower concentration of hyaluronic acid than other dermal fillers can deliver same effect. The product is an ultra-smooth gel known for a more natural look with minimal bruising and swelling perfect for the eye area.

Juvéderm® VOLBELLA is a temporary filler which has an estimated duration of 12-15 months. However, results in the eye area are longer-lasting.

Dr Tim Pearce continues:

“Because there is so little movement in the area, the treatment can last a very long time. I generally advise up to 2 years, but one of the first treatments I did has not needed a touch up in 5 years!”

A further appeal of the Juvéderm® range is the inclusion of Lidocaine local anaesthetic for a comfortable experience even in the sensitive eye area, especially when used with Dr Pearce’s Tear Trough injection techniques.

Dr Tim Pearce concludes:

“The eye area is the most delicate area of the face to inject, yet clients often comment on how slowly and gently the injections are applied - it's very different to your last flu vaccination! This aspect of the injection makes it surprisingly comfortable to inject, with many clients reporting that it is a completely painless experience.”

“However, the tear trough area does require advanced technique. If you are researching this area, be very sure that you only see an expert, it is not an area to trust to the novice or occasional injector.”

At SkinViva, all cosmetic injections are carried out by experienced Aesthetic Doctors who have undergone specific training in non-surgical treatments. The team of Aesthetic Doctors practice in under the watchful eye of Dr Tim Pearce MB ChB BSc (Hons) MRCGP in a network of over 85 skin treatment clinic locations over the North West of England, including Cheshire, Lancashire and Derbyshire; in addition to their own flagship clinic based in the Castlefield area of Manchester.

SkinViva was established in 2008 and have an excellent reputation for delivering excellent results and high patient satisfaction through their professional skin treatments. Popular skin treatments include wrinkle-relaxing injections, dermal fillers, micro-needling and skin peels.

Client Liaison, SkinViva, http://www.skinviva.com, +44 1618651141, [email protected]

Modal title

Before and After
Before and After
SkinViva Logo
SkinViva Logo
Dr Tim Pearce MB ChB BSc (Hons) MRCGP
Dr Tim Pearce MB ChB BSc (Hons) MRCGP
Manchester Clinic
Manchester Clinic
Before and After SkinViva Logo Dr Tim Pearce MB ChB BSc (Hons) MRCGP Manchester Clinic

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.